Kaposi's sarcoma: Advances and perspectives
Identifieur interne : 00BE47 ( Main/Exploration ); précédent : 00BE46; suivant : 00BE48Kaposi's sarcoma: Advances and perspectives
Auteurs : Robert A. Schwartz [États-Unis]Source :
- Journal of the American Academy of Dermatology [ 0190-9622 ] ; 1996.
Abstract
Kaposi's sarcoma (KS) is an unusual neoplasm that has proved to be an enigma in many ways since its original description by Kaposi in 1872. Its epidemiology has stimulated tremendous interest, amplified markedly in 1981 when it became known as an original defining part of the complex of immune disorders now known as AIDS. The cell of origin, etiology, and therapy for both AIDS-associated and AIDS-unassociated KS continue as matters of intense investigation. In fact, whether it is a reactive hyperplasia or a true malignancy is still a matter of debate, as is the concept of multicentricity versus metastases. Epidemiologic studies suggest that a separate agent apart from HIV-1 may cause KS. A newly postulated KS-associated herpes virus may be linked. The role of the HIV-1 tat gene product, basic fibroblast growth factor, scatter factor, oncostatin M, and other factors that regulate the growth of KS cells are discussed, as well as therapeutic options.
Url:
DOI: 10.1016/S0190-9622(96)90018-3
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 006C75
- to stream Istex, to step Curation: 006C75
- to stream Istex, to step Checkpoint: 004246
- to stream Main, to step Merge: 00C701
- to stream Main, to step Curation: 00BE47
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Kaposi's sarcoma: Advances and perspectives</title><author><name sortKey="Schwartz, Robert A" sort="Schwartz, Robert A" uniqKey="Schwartz R" first="Robert A." last="Schwartz">Robert A. Schwartz</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:E7B9C5CED04E64303D0D480461268913023999E4</idno><date when="1996" year="1996">1996</date><idno type="doi">10.1016/S0190-9622(96)90018-3</idno><idno type="url">https://api.istex.fr/document/E7B9C5CED04E64303D0D480461268913023999E4/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">006C75</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">006C75</idno><idno type="wicri:Area/Istex/Curation">006C75</idno><idno type="wicri:Area/Istex/Checkpoint">004246</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">004246</idno><idno type="wicri:doubleKey">0190-9622:1996:Schwartz R:kaposi:s:sarcoma</idno><idno type="wicri:Area/Main/Merge">00C701</idno><idno type="wicri:Area/Main/Curation">00BE47</idno><idno type="wicri:Area/Main/Exploration">00BE47</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Kaposi's sarcoma: Advances and perspectives</title><author><name sortKey="Schwartz, Robert A" sort="Schwartz, Robert A" uniqKey="Schwartz R" first="Robert A." last="Schwartz">Robert A. Schwartz</name><affiliation wicri:level="2"><country xml:lang="fr">États-Unis</country><wicri:regionArea>From Dermatology, New Jersey Medical School. Newark, New Jersey</wicri:regionArea><placeName><region type="state">New Jersey</region></placeName></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of the American Academy of Dermatology</title><title level="j" type="abbrev">YMJD</title><idno type="ISSN">0190-9622</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1996">1996</date><biblScope unit="volume">34</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="supplement">P1</biblScope><biblScope unit="page" from="804">804</biblScope><biblScope unit="page" to="814">814</biblScope></imprint><idno type="ISSN">0190-9622</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0190-9622</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Kaposi's sarcoma (KS) is an unusual neoplasm that has proved to be an enigma in many ways since its original description by Kaposi in 1872. Its epidemiology has stimulated tremendous interest, amplified markedly in 1981 when it became known as an original defining part of the complex of immune disorders now known as AIDS. The cell of origin, etiology, and therapy for both AIDS-associated and AIDS-unassociated KS continue as matters of intense investigation. In fact, whether it is a reactive hyperplasia or a true malignancy is still a matter of debate, as is the concept of multicentricity versus metastases. Epidemiologic studies suggest that a separate agent apart from HIV-1 may cause KS. A newly postulated KS-associated herpes virus may be linked. The role of the HIV-1 tat gene product, basic fibroblast growth factor, scatter factor, oncostatin M, and other factors that regulate the growth of KS cells are discussed, as well as therapeutic options.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>New Jersey</li></region></list><tree><country name="États-Unis"><region name="New Jersey"><name sortKey="Schwartz, Robert A" sort="Schwartz, Robert A" uniqKey="Schwartz R" first="Robert A." last="Schwartz">Robert A. Schwartz</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00BE47 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 00BE47 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:E7B9C5CED04E64303D0D480461268913023999E4
|texte= Kaposi's sarcoma: Advances and perspectives
}}
| This area was generated with Dilib version V0.6.31. |  |